GeneDx Holdings annual gross margin
2019
2020
2021
2022
2023
2024
2025
GeneDx Holdings's gross margin was 69.74% for fiscal 2025.
View full GeneDx Holdings company overview| Fiscal year | Period ended | Gross margin | Change (percentage points) |
|---|---|---|---|
| 2025 | 2025-12-31 | 69.74% | +6.10 pp |
| 2024 | 2024-12-31 | 63.64% | +19.21 pp |
| 2023 | 2023-12-31 | 44.43% | +55.83 pp |
| 2022 | 2022-12-31 | −11.40% | −3.57 pp |
| 2021 | 2021-12-31 | −7.82% | −10.07 pp |
| 2020 | 2020-12-31 | 2.25% | −39.95 pp |
| 2019 | 2019-12-31 | 42.20% | — |
| Fiscal quarter | Period ended | Gross margin | Change (percentage points) |
|---|---|---|---|
| Q2 2026 | 2026-06-30 | 68.37% | −0.68 pp |
| Q1 2026 | 2026-03-31 | 66.71% | −0.42 pp |
| Q4 2025 | 2025-12-31 | 69.65% | +0.43 pp |
| Q3 2025 | 2025-09-30 | 72.40% | +10.19 pp |
| Q2 2025 | 2025-06-30 | 69.04% | +8.13 pp |
| Q1 2025 | 2025-03-31 | 67.13% | +7.19 pp |
| Q4 2024 | 2024-12-31 | 69.22% | +15.66 pp |
| Q3 2024 | 2024-09-30 | 62.22% | +14.83 pp |
| Q2 2024 | 2024-06-30 | 60.91% | +22.40 pp |
| Q1 2024 | 2024-03-31 | 59.93% | +24.61 pp |
| Q4 2023 | 2023-12-31 | 53.56% | +80.17 pp |
| Q3 2023 | 2023-09-30 | 47.39% | +31.11 pp |
| Q2 2023 | 2023-06-30 | 38.51% | +120.34 pp |
| Q1 2023 | 2023-03-31 | 35.32% | +24.89 pp |
| Q4 2022 | 2022-12-31 | −26.61% | −21.76 pp |
| Q3 2022 | 2022-09-30 | 16.28% | +35.52 pp |
| Q2 2022 | 2022-06-30 | −81.83% | −79.36 pp |
| Q1 2022 | 2022-03-31 | 10.43% | +17.16 pp |
| Q4 2021 | 2021-12-31 | −4.85% | −10.24 pp |
| Q3 2021 | 2021-09-30 | −19.24% | — |
| Q2 2021 | 2021-06-30 | −2.48% | — |
| Q1 2021 | 2021-03-31 | −6.73% | — |
| Q3 2020 | 2020-09-30 | 5.38% | — |
Over the last five reported fiscal years, GeneDx Holdings's gross margin increased from 2.25% to 69.74%, a change of +67.50 percentage points. The latest reported quarter, Q2 2026, shows 68.37%.
Gross margin measures the percentage of revenue remaining after the direct costs of producing goods or services. It helps show how efficiently a company turns sales into gross profit before operating expenses.
TickerStat calculates gross margin as SEC-reported gross profit divided by SEC-reported revenue for the same fiscal period. Changes are shown in percentage points. Fiscal periods can differ from calendar years, so exact period-end dates are included.
Review GeneDx Holdings filings at SEC.gov ↗